Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma

MANABU EMI, YOICHI HMAI, TORU YOSHIKAWA, RYOSUKE HIROHATA, MANATO OSAWA, MORIHITO OKADA, YUJI MURAKAMI and IKUNO NISHIBUCHI
Anticancer Research May 2022, 42 (5) 2791-2795; DOI: https://doi.org/10.21873/anticanres.15759
MANABU EMI
1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: emirin{at}hiroshima-u.ac.jp
YOICHI HMAI
1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TORU YOSHIKAWA
1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RYOSUKE HIROHATA
1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MANATO OSAWA
1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MORIHITO OKADA
1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUJI MURAKAMI
2Department of Radiology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IKUNO NISHIBUCHI
2Department of Radiology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 42 no. 5 2791-2795
DOI 
https://doi.org/10.21873/anticanres.15759
PMID 
35489771

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 3, 2022
  • Revision received April 11, 2022
  • Accepted April 12, 2022
  • Published online April 30, 2022.

Copyright & Usage 
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. MANABU EMI1⇑,
  2. YOICHI HMAI1,
  3. TORU YOSHIKAWA1,
  4. RYOSUKE HIROHATA1,
  5. MANATO OSAWA1,
  6. MORIHITO OKADA1,
  7. YUJI MURAKAMI2 and
  8. IKUNO NISHIBUCHI2
  1. 1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
  2. 2Department of Radiology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
  1. Correspondence to: Manabu Emi, MD, Ph.D., Kasumi 1-2-3, Minami-Ku, Hiroshima 734-8553, Japan. Tel: +81 822575869, Fax: +81 822567109, e-mail: emirin{at}hiroshima-u.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 5 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 42, Issue 5
May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
16 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma
MANABU EMI, YOICHI HMAI, TORU YOSHIKAWA, RYOSUKE HIROHATA, MANATO OSAWA, MORIHITO OKADA, YUJI MURAKAMI, IKUNO NISHIBUCHI
Anticancer Research May 2022, 42 (5) 2791-2795; DOI: 10.21873/anticanres.15759

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma
MANABU EMI, YOICHI HMAI, TORU YOSHIKAWA, RYOSUKE HIROHATA, MANATO OSAWA, MORIHITO OKADA, YUJI MURAKAMI, IKUNO NISHIBUCHI
Anticancer Research May 2022, 42 (5) 2791-2795; DOI: 10.21873/anticanres.15759
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • A Multi-institutional Study to Diagnose the Risk of Lymph Node Metastasis Using a CRP Genetic Polymorphism Test Kit in pT1, cN0 Thoracic Esophageal Squamous Cell Carcinoma
  • Google Scholar

More in this TOC Section

  • A Reminder App for Optimizing Bladder Filling During Radiotherapy for Prostate Cancer: A Pre-study in Healthy Volunteers
  • Timing and Risk Factors for Hyperglycemia Associated With Anamorelin Administration
  • Identification of Risk Factors for the Local Recurrence of Hepatocellular Carcinoma Post-radiofrequency Ablation
Show more Clinical Studies

Keywords

  • Superficial esophageal carcinoma
  • endoscopic resection
  • esophagectomy
  • chemoradiotherapy
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire